Literature DB >> 1924020

Management of carcinoid syndrome.

A Saini1, J Waxman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1924020      PMCID： PMC2398908          DOI： 10.1136/pgmj.67.788.506

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.

Authors:  K Oberg; I Norheim; E Lind; G Alm; G Lundqvist; L Wide; B Jonsdottir; A Magnusson; E Wilander
Journal:  Cancer Treat Rep       Date:  1986-11

2.  Therapy for symptoms in the carcinoid syndrome.

Authors:  M Coupe; S Levi; M Ellis; B Clarke; J A Morris; E A Alstead; D J Allison; H J Hodgson
Journal:  Q J Med       Date:  1989-11

3.  A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study.

Authors:  R M Bukowski; K G Johnson; R F Peterson; R L Stephens; S E Rivkin; B Neilan; J H Costanzi
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

4.  The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome.

Authors:  K Oberg; I Norheim; E Theodorsson; H Ahlman; G Lundqvist; L Wide
Journal:  J Clin Endocrinol Metab       Date:  1989-04       Impact factor: 5.958

5.  Rapid reversal of carcinoid crisis with a somatostatin analogue.

Authors:  L K Kvols; J K Martin; H M Marsh; C G Moertel
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

6.  Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.

Authors:  C G Moertel; J A Hanley
Journal:  Cancer Clin Trials       Date:  1979

7.  Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study.

Authors:  D I Jodrell; I E Smith
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.

Authors:  J M Conlon; C F Deacon; G Richter; F Stöckmann; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1987-01       Impact factor: 2.423

Review 9.  Treatment of the carcinoid tumor and the malignant carcinoid syndrome.

Authors:  C G Moertel
Journal:  J Clin Oncol       Date:  1983-11       Impact factor: 44.544

10.  Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon.

Authors:  K Oberg; I Norheim; G Alm
Journal:  Eur J Cancer Clin Oncol       Date:  1989-10
  10 in total
  1 in total

Review 1.  Cutaneous scleroderma in association with carcinoid syndrome.

Authors:  G Durward; S Blackford; D Roberts; M K Jones
Journal:  Postgrad Med J       Date:  1995-05       Impact factor: 2.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.